MA
REGN icon

MYDA Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

MYDA Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,000
Closed -$1.64M – 164
2023
Q1 		$1.64M Buy
2,000
+800
+67% +$603K 0.69% 40
2022
Q4 		$866K Sell
1,200
-800
-40% -$590K 0.62% 45
2022
Q3 		$1.38M Buy
+2,000
New +$1.26M 0.77% 48
2022
Q1 		– Sell
-2,400
Closed -$1.52M – 269
2021
Q4 		$1.52M Sell
2,400
-8,300
-78% -$5.1M 0.48% 77
2021
Q3 		$6.47M Buy
10,700
+6,700
+168% +$4.16M 2.35% 8
2021
Q2 		$2.23M Buy
+4,000
New +$2.03M 0.62% 51
2020
Q4 		– Hold
0
– – – 233
2020
Q3 		– Sell
-4,000
Closed -$2.43M – 153
2020
Q2 		$2.5M Sell
4,000
-700
-15% -$397K 2.37% 22
2020
Q1 		$2.29M Buy
+4,700
New +$1.94M 2.6% 19

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return